Research Articles Library
Literature Analysis Tools
Advanced Search
Filter by PMID, year, source, DOI and other criteria
Literature Analysis
Analyze research trends and hotspots
Batch Export
Export search results to Excel/PDF
Antibodies to synthetic polyribonucleotides in spouses of patients with inflammatory bowel disease
Publication Year: 1978 Source: Lancet PMID: 77414 DOI: 10.1016/s0140-6736(78)90298-2
Not found
Vaccination against infectious bronchitis and the immunosuppressive effects of infectious bursal disease
Publication Year: 1978 Source: Poult Sci PMID: 209433 DOI: 10.3382/ps.0570386
Not found
Susceptibility of chicks to infectious bursal disease (IBD) following vaccination of their parents with live IBD vaccine
Publication Year: 1978 Source: Vet Rec PMID: 213872 DOI: 10.1136/vr.103.13.281
The unraveling of the immuno-pathobiology of inflammatory bowel disease (IBD) in the past three decades has ushered in a new era of translational medicine. The biotechnology revolution has resulted in a paradigm shift in how clinicians view and treat IBD. Anti-tumor necrosis factor (TNF)-α strategies using infliximab and adalimumab currently …
Escherichia coli antibodies in patients with inflammatory bowel disease
Publication Year: 1978 Source: Gut PMID: 344155 DOI: 10.1136/gut.19.2.108
Not found
Ankylosing spondylitis and inflammatory bowel disease. III. Clinical characteristics and results of histocompatibility typing (HLA B27) in 50 patients with both ankylosing spondylitis and inflammatory bowel disease
Publication Year: 1978 Source: Ann Rheum Dis PMID: 629602 DOI: 10.1136/ard.37.1.36
Not found
Significance of anergy to dinitrochlorobenzene (DNCB) in inflammatory bowel disease: family and postoperative studies
Publication Year: 1978 Source: Gut PMID: 648933 DOI: 10.1136/gut.19.4.249
Inflammatory bowel diseases (IBD)-and in particular Crohn's disease-are immune-mediated processes that result in denuded intestinal mucosa and can produce decreased appetite, weight loss, and systemic inflammation. Current treatments include anti-inflammatory medications, immunomodulators, and feeding interventions. Ghrelin is an endogenous orexigenic hormone that directly stimulates growth hormone release, increases gut motility, …
Skin test reactivity in inflammatory bowel disease in the United States and Czechoslovakia
Publication Year: 1978 Source: Am J Dig Dis PMID: 665629 DOI: 10.1007/BF01072417
Not found
The generalized sib pair IBD distribution: its use in the detection of linkage
Publication Year: 1978 Source: Ann Hum Genet PMID: 686687 DOI: 10.1111/j.1469-1809.1978.tb00933.x
All medicinal compounds sold in the United States for inflammatory bowel disease (IBD) are regulated by the Food and Drug Administration (FDA) via a number of regulations dating back to 1906. The primary contemporary role of the FDA is in the assessment of safety and efficacy, and subsequent marketing, of …
The affected sib pair IBD distribution for HLA-linked disease susceptibility genes
Publication Year: 1978 Source: Tissue Antigens PMID: 705775 DOI: 10.1111/j.1399-0039.1978.tb01303.x
Pyoderma gangrenosum (PG) is an immune-mediated inflammatory skin condition representing one of the most distinct extraintestinal manifestations of inflammatory bowel disease (IBD). PG occurs independently from intestinal disease activity in about 1-2% of patients suffering from ulcerative colitis or Crohn's disease and is characterized by chronic deep skin ulcers whose …
Hemostatic alterations in inflammatory bowel disease: response to therapy
Publication Year: 1978 Source: Am J Dig Dis PMID: 717349 DOI: 10.1007/BF01072463
Not found
Need more literature?
The current database contains 98453 research articles. If you need to search for more literature or perform AI analysis, please use our knowledge acquisition module or explore external literature resources.
External Resources: Access comprehensive literature databases worldwide